跳至主要内容
临床试验/JPRN-UMIN000000969
JPRN-UMIN000000969已完成4 期

Effects of fenofibrate or eiocosapentaenoic acid(EPA) on glucose metabolism, fat distribution, adipocytokines and inflammatory cytokines in type 2 Diabetes. - FiEPA study

Kobe University Hospital0 个研究点目标入组 50 人开始时间: 2008年1月7日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Severe hypercholesterolemia(LDL>140mg/dl) 2. Severe deficiency of insulin secretion 3. Severe renal dysfunction (serum creatinin>2.0mg/dl) 4. Severe liver dysfunction (AST, ALT>50IU/ml) 5. Severe herat failure 6. History of hypersensitivity to pioglitazone or metformin. 7. During the pregnancy and nursing 8. Inadequately BS contrilled (FBG>150mg/dl) 9. Inadequate to entry this study

研究者

相似试验

Effects of fenofibrate or eiocosapentaenoic... | 临床试验